Healthcare Startup Rotations
Medical students and residents rotate on different specialty services during their education and training.
The Meth Epidemic We Forgot About
How meth became an epidemic in America, and what’s happening now that overdose deaths have faded from the headline news.
Rural Hospital Merger Ends Emergency Department
“Just because they aren’t leaving the ER doesn’t mean they are happy where they are,” he said. “They don’t have ...
Killing Them Quietly
A war is raging in America today, between physicians treating pain and addiction, and the United States federal government.
The Plot to Overthrow Dobbs
This landmark case, which overturned the long-standing precedent set by Roe v. Wade, has stirred significant debate and public opinion.
National Opioid Settlement Injunction
How does this fifty-four-page document up-end a critical part of our health care system with almost no one knowing?
A Look at the Different Types of Stethoscopes
Stethoscopes come in various shapes and sizes, and each one is important. Learn about the different types of stethoscopes used ...
Propublica Examines Racial Biases in Drug Investigations
Qiu He remembers sitting handcuffed on her front porch, her two small children huddled next to her, as state anti-drug ...
Processed Food Fight
Some researchers are targeting artificial foods as a health problem. As with so many dietary issues the evidence tells a ...
The Politics of Fentanyl
The 2024 US election is undoubtedly significant, and to grasp its implications, it is crucial to delve into fentanyl and ...
Another Year, More Overdose Records
The latest data from the CDC has revealed that drug overdoses in the United States have reached another grim milestone ...
How to Recognize Toxic Stress
COVID-19 taught most people that the line between tolerable and toxic stress – defined as persistent demands – varies widely.
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read morePopular
-
Growth Hormone Secretagogues and the Longevity Trade-Off
-
The IRA’s Drug Negotiation Mechanism Meets the Rebate Industrial Complex
-
The Second Reader That Never Sleeps: Large Language Models and Clinical Decision-Making
-
GLP-1 Agonists Beyond Obesity: The Expanding Therapeutic and Optimization Frontier
-
The Peptide Underground: Clinical Evidence, Compounding Markets, and the Optimization Economy
